(Press-News.org) AUGUST 23, 2024, NEW YORK – A Ludwig Cancer Research study has identified a metabolic switch in the immune system’s T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and a T cell subtype found in tumors that drives anti-tumor responses during immunotherapy.
Led by Ludwig Lausanne’s Ping-Chih Ho and Alessio Bevilacqua and published in the current issue of Science Immunology, the study identifies PPARβ/δ, a master regulator of gene expression, as that essential molecular switch. Ho, Bevilacqua and their colleagues also show that the switch’s dysfunction compromises T cell “memory” of previously encountered viruses as well as the induction of anticancer immune responses in mice.
“Our findings suggest that we might be able to engage this switch pharmacologically to improve the efficacy of cancer immunotherapies,” said Ho.
When killer (or CD8+) T cells, which kill sick and cancerous cells, are activated by their target antigen, they switch on metabolic pathways that most other healthy cells only use when starved of oxygen. This type of metabolism—involving a metabolic process known as aerobic glycolysis—supports multiple processes essential to the killer T cell’s ability to proliferate and destroy its target cells.
Most killer T cells die off after they’ve cleared an infection. A few, however, transform into central memory CD8+ T cells (Tcms) that linger in the circulation to establish what we call immunity: the ability to mount a swift and lethal response to the same pathogen if it is ever encountered again. To achieve this transformation, T cells switch off aerobic glycolysis and otherwise adapt their metabolism to persist over the long term in tissues or in the circulation. How precisely they do this was until now unknown.
Aware that PPARβ/δ activates many of the metabolic processes characteristic of Tcms, Ho, Bevilacqua and their colleagues hypothesized it might play a key role in Tcm formation. They examined immunologic gene expression data collected from yellow fever vaccine recipients long after vaccination and, as expected, saw that the PPARβ/δ was produced abundantly in their Tcms.
Their studies in mice revealed that PPARβ/δ is activated in T cells not in the peak phase of the immune response to viral infection but as that response winds down. Further, CD8+ T cells were unable to make the metabolic switch required to become circulating Tcms if they failed to express PPARβ/δ. Disrupting its expression impaired survival of such Tcms and resident memory T cells in the intestines following infection.
The researchers show that T cell exposure to interleukin-15—an immune factor important for Tcm formation—and their expression of a protein named TCF1 engages the PPARβ/δ pathway. TCF1 is already known to be critical to the rapid expansion of Tcms when they encounter their target pathogen. The researchers show in this study that it is also important to the maintenance of TCMs.
As it happens, TCF1 expression is a hallmark of a subset of CD8+ T cells—progenitor-exhausted T cells—that are found in tumors. These progenitor-exhausted T cells follow one of two paths: they either become completely lethargic, “terminally exhausted” T cells; or, given the appropriate stimulus, proliferate to produce “effector” CD8+ T cells that kill cancer cells. Checkpoint blockade immunotherapies, like anti-PD-1 antibodies, can provide such stimulus.
The observation that TCF1 modulates the PPARβ/δ pathway in T cells raised the possibility that it might also be essential to the formation and maintenance of progenitor-exhausted T cells. The researchers showed that this is indeed the case. Deleting the PPARβ/δ gene from T cells led to the loss of progenitor-exhausted T cells in a mouse model of melanoma. They also demonstrate that the PPARβ/δ pathway curtails the tendency of progenitor-exhausted T cells to stagger toward terminal exhaustion.
To assess the therapeutic potential of their findings, Ho, Bevilacqua and their colleagues exposed T cells to a molecule that stimulates PPARβ/δ activity and used the treated cells against a mouse model of melanoma. These cells delayed the growth of melanoma tumors in mice more efficiently than their untreated counterparts and bore biochemical hallmarks of progenitor exhausted T cells primed to generate cancer-killing descendants.
“Based on these findings,” said Bevilacqua, “we suggest that targeting PPARβ/δ signaling may be a promising approach to improve T cell-mediated anti-tumor immunity.
How exactly this might be achieved in people is a subject for further study that will doubtless be pursued by the Ho laboratory.
This study was supported by Ludwig Cancer Research, the Swiss National Science Foundation, the European Research Council, the Swiss Cancer Foundation, the Cancer Research Institute, Helmut Horten Stiftung, the Melanoma Research Alliance, the Taiwan Ministry of Science and Technology, the NYU Abu Dhabi Research Institute Award and Academia Sinica.
Ping-Chih Ho is a member of the Lausanne Branch of the Ludwig Institute for Cancer Research and a full professor at the University of Lausanne.
# # #
About Ludwig Cancer Research
Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 50 years. Ludwig combines basic science with the translation and clinical evaluation of its discoveries to accelerate the development of new cancer diagnostics, therapies and prevention strategies. Since 1971, Ludwig has invested nearly $3 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. To learn more, visit www.ludwigcancerresearch.org.
For additional information please contact communications@ludwigcancerresearch.org.
END
COLUMBUS, Ohio – Nearly half of counties in the United States have at least one ‘pharmacy desert’ where there is no retail pharmacy within 10 miles, according to a new study published by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
“As pharmacies close, more and more Americans are left without easy access to medications, with disproportionate consequences on certain communities. We found that patients in counties with higher social vulnerabilities and fewer primary care providers were up to 40% more likely to reside in a region ...
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
EAST LANSING, Mich. – A study out of Michigan State University found that nondeceptive placebos, or placebos given with people fully knowing they are placebos, effectively manage stress — even when the placebos are administered remotely.
Researchers recruited participants experiencing prolonged stress from the COVID-19 pandemic for a two-week randomized controlled trial. Half of the ...
EAST LANSING, Mich. – A team of researchers at Michigan State University has discovered a set of methods that enabled the first successful CRISPR-based genome editing in Nile grass rats.
The study, published in BMC Biology, is the first to successfully edit genomes in Nile grass rats. As diurnal rodents, Nile grass rats have similar sleep/awake patterns to humans which could be advantageous in preclinical or translational research.
Currently, preclinical research relies heavily on laboratory mice, which are nocturnal rodents who are active at night and sleep during the day. With these different sleep patterns, diurnal and nocturnal ...
Underserved high school students often lack access to artificial intelligence education that could prepare them for future careers in technology. Researchers at the University of Virginia School of Engineering and Applied Science and Clemson University are hoping to change that.
To help bridge the educational divide, the research team received a $1 million grant from the National Science Foundation to democratize access to AI education. Future fair and equitable technologies depend on a robust AI education, and expanding access to that education is crucial.
The project is part of the NSF’s Experiential Learning for ...
Children’s exposure to food and drink ads during kids’ TV shows has dropped substantially since food and beverage makers pledged to stop advertising unhealthy fare during children’s TV shows. Yet, according to research from the University of Illinois Chicago, children under 12 still see more than 1,000 food-related ads a year, most of them for unhealthy products.
For the study, published in JAMA Network Open, researchers analyzed television ratings and advertising data from 2013 through 2022. The study authors found that a dramatic decline in food and drink advertisements during kids’ shows did not ...
New research from Oregon Health & Science University reveals negative health consequences for people who are overweight and ignore their body’s signals to sleep at night, with specific differences between men and women.
The study published this week in The Journal of Clinical Endocrinology & Metabolism.
“This study builds support for the importance of good sleep habits,” said lead author Brooke Shafer, Ph.D., a postdoctoral researcher in the Sleep, Chronobiology and Health Laboratory in the OHSU School of Nursing. “Sleep practices, like going to bed when you’re tired or setting aside your screen at ...
San Francisco, CA (August 12, 2024) – Pendulum Therapeutics, in collaboration with BiomeSense, announces the launch of an innovative new pilot study entitled "Detection of Akkermansia muciniphila Utilizing Serial Longitudinal Samples with the BiomeSense GutLab™: An Open-Label Proof of Concept Study." Pendulum Therapeutics and BiomeSense are two biotech companies at the forefront of microbiome science. Their groundbreaking research aims to advance the scientific understanding of the human microbiome by focusing on continuous detection of Akkermansia muciniphila, a keystone strain in the gut microbiome, using a new data generation technology.
About ...
RIVERSIDE, Calif. -- A multi-institutional team of scientists in the United States, led by physicist Peng Wei at the University of California, Riverside, has developed a new superconductor material that could potentially be used in quantum computing and be a candidate “topological superconductor.”
Topology is the mathematics of shape. A topological superconductor uses a delocalized state of an electron or hole (a hole behaves like an electron with positive charge) to carry quantum information and process data in a robust manner.
The researchers report today in Science Advances that they combined trigonal tellurium ...
When NASA’s Double Asteroid Redirection Test (DART) spacecraft collided with an asteroid moon called Dimorphos in 2022, the moon was significantly deformed—creating a large crater and reshaping it so dramatically that the moon derailed from its original evolutionary progression—according to a new study. The study’s researchers believe that Dimorphos may start to “tumble” chaotically in its attempts to move back into gravitational equilibrium with its parent asteroid named Didymos.
“For ...
People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of Alzheimer’s disease, according to new research from Washington University School of Medicine in St. Louis.
The discovery suggests a new avenue of research through which to seek Alzheimer’s treatments, said Matthew Brier, MD PhD, an assistant professor of neurology and of radiology and the study’s first author.
“Our findings imply that some component of the biology of multiple sclerosis, ...
